Ausgabe 2/2008
Inhalt (26 Artikel)
Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction
Yu Chuan Tai, Sining Chen, Giovanni Parmigiani, Alison P Klein
Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis
Jai Grewal, Santosh Kesari
Tissue factor, angiogenesis and tumour progression
Joanne E Bluff, Nicola J Brown, Malcolm WR Reed, Carolyn A Staton
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer
Aparna Mitra, Rebecca A Fillmore, Brandon J Metge, Mathur Rajesh, Yaguang Xi, Judy King, Jingfang Ju, Lewis Pannell, Lalita A Shevde, Rajeev S Samant
Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG)
Alexander Wall, Thorsten Persigehl, Peter Hauff, Kai Licha, Michael Schirner, Silke Müller, Angelika von Wallbrunn, Lars Matuszewski, Walter Heindel, Christoph Bremer
Inflammation and breast cancer. Metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer
Carlo V Hojilla, Geoffrey A Wood, Rama Khokha
Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials
Marianne Kyndi, Flemming B Sørensen, Helle Knudsen, Jan Alsner, Marie Overgaard, Hanne M Nielsen, Jens Overgaard
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M Fillmore, Charlotte Kuperwasser
Evaluation of the current knowledge limitations in breast cancer research: a gap analysis
Alastair Thompson, Keith Brennan, Angela Cox, Julia Gee, Diana Harcourt, Adrian Harris, Michelle Harvie, Ingunn Holen, Anthony Howell, Robert Nicholson, Michael Steel, Charles Streuli
PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer
Cornelia Liedtke, Luca Cardone, Attila Tordai, Kai Yan, Henry L Gomez, Luis J Barajas Figureoa, Rebekah E Hubbard, Vicente Valero, Eduardo A Souchon, W Fraser Symmans, Gabriel N Hortobagyi, Alberto Bardelli, Lajos Pusztai
The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome
Alison J Butt, C Marcelo Sergio, Claire K Inman, Luke R Anderson, Catriona M McNeil, Amanda J Russell, Marco Nousch, Thomas Preiss, Andrew V Biankin, Robert L Sutherland, Elizabeth A Musgrove
Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1gene
Jennifer K Hockings, Stephanie C Degner, Sherif S Morgan, Michael Q Kemp, Donato F Romagnolo
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast
Gunter von Minckwitz, Hans-Peter Sinn, Günter Raab, Sibylle Loibl, Jens-Uwe Blohmer, Holger Eidtmann, Jörn Hilfrich, Elisabeth Merkle, Christian Jackisch, Serban D Costa, Angelika Caputo, Manfred Kaufmann
Cancer and fertility preservation: fertility preservation in breast cancer patients
Theodoros Maltaris, Michael Weigel, Andreas Mueller, Marcus Schmidt, Rudolf Seufert, Franz Fischl, Heinz Koelbl, Ralf Dittrich
Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk
Sascha Abbas, Alexandra Nieters, Jakob Linseisen, Tracy Slanger, Silke Kropp, Elke Jonny Mutschelknauss, Dieter Flesch-Janys, Jenny Chang-Claude
Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study
Heather Ward, Gaelle Chapelais, Gunter GC Kuhnle, Robert Luben, Kay-Tee Khaw, Sheila Bingham
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
Michael Rugaard Jensen, Joseph Schoepfer, Thomas Radimerski, Andrew Massey, Chantale T Guy, Josef Brueggen, Cornelia Quadt, Alan Buckler, Robert Cozens, Martin J Drysdale, Carlos Garcia-Echeverria, Patrick Chène
Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy
Emma Niméus-Malmström, Morten Krogh, Per Malmström, Carina Strand, Irma Fredriksson, Per Karlsson, Bo Nordenskjöld, Olle Stål, Görel Östberg, Carsten Peterson, Mårten Fernö
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer
Yasmine Nadler, Robert L Camp, Jennifer M Giltnane, Christopher Moeder, David L Rimm, Harriet M Kluger, Yuval Kluger
TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells
Jillian Howlin, Jeanette Rosenkvist, Tommy Andersson
Evaluation of biological pathways involved in chemotherapy response in breast cancer
Attila Tordai, Jing Wang, Fabrice Andre, Cornelia Liedtke, Kai Yan, Christos Sotiriou, Gabriel N Hortobagyi, W Fraser Symmans, Lajos Pusztai
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study
Gretchen L Gierach, James V Lacey Jr, Arthur Schatzkin, Michael F Leitzmann, Douglas Richesson, Albert R Hollenbeck, Louise A Brinton